Skip to main content
Login
Contact
Subscribe
Search form
Search
The Evening Leader?
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Service Directory
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Amgen
(NQ:
AMGN
)
234.04
USD
+0.20 (+0.09%)
Streaming Delayed Price
/ Updated:
3:11 PM EST, Dec 11, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
882,549
Open
234.03
Bid (Size)
233.94 (2)
Ask (Size)
233.99 (1)
Prev. Close
233.84
Today's Range
233.03 - 234.97
52wk Range
166.30 - 235.80
Shares Outstanding
661,706,000
Dividend Yield
2.26%
Performance
YTD
+21.96%
+21.96%
1 Month
+6.04%
+6.04%
3 Month
+18.88%
+18.88%
6 Month
+34.03%
+34.03%
1 Year
+20.58%
+20.58%
Top News
More News
Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting
December 10, 2019
Treatment With KYPROLIS, Dexamethasone and DARZALEX (KdD) Resulted in a Significant Progression-Free Survival (PFS) Benefit
Read More
from
PR Newswire
Amgen Selects Location For R&D Facility In The South San Francisco Biotechnology Hub
December 09, 2019
Amgen Signs Lease With Biomed Realty for New Gateway of Pacific Campus Facility
Read More
from
PR Newswire
More News
Read More
Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease
December 09, 2019
from
PR Newswire
FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)
December 06, 2019
from
PR Newswire
TQQQ, AAPL, CMCSA, AMGN: Large Inflows Detected at ETF
December 09, 2019
category
ETFs
from
ETF Channel
Is Rigel Pharmaceuticals Stock a Buy?
Today 7:00 EST
category
NVS
,
GRFS
,
AMGN
, and 2 more.
from
Motley Fool
Drugmakers have spent a record $342 billion on M&A in 2019
December 09, 2019
category
Biotechnology
,
Company Announcements/Warnings
,
SNY
, and 19 more.
from
MarketWatch
9 Most Overbought Stocks In The S&P 500
December 09, 2019
category
INCY
,
Benzinga
,
relative strength index
, and 13 more.
from
Benzinga
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
December 07, 2019
category
companyNews
from
Reuters: Company News
Better Buy: Biogen vs. Amgen
December 08, 2019
category
RHHBY
,
BIIB
,
AMGN
, and 2 more.
from
Motley Fool
UPDATE 1-FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug
December 06, 2019
category
companyNews
from
Reuters: Company News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
X
Username
*
Password
*
Request new password